EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Multi‐Omic Profiling Reveals Immune Cell Priming Signature Linked to Lupus Prognosis

Michael A Smith, Dominic Sinibaldi, Saifur Rahman, Chia-Chien Chiang, Anna M Hansen, Jill Henault, Carlos P Roca, Shu Wang, Kamelia Zerrouki, Rebecca Filippi, Christopher Groves, Zerai Manna und 12 weitere

Arthritis & Rheumatology · 2026

DOI: 10.1002/art.70105 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, 2026. Verfasst von Michael A Smith und 23 weiteren Autor:innen. Beteiligte Einrichtung: BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Intramural NIH HHS, AstraZeneca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Systemic lupus erythematosus (SLE) is a multiorgan disease with widespread immune dysregulation and significant unmet clinical need. Blood‐based gene expression studies have advanced our understanding of SLE pathogenesis but may overlook critical tissue‐specific mechanisms that drive disease heterogeneity and progression. We posited that integrated multidimensional profiling could reveal novel molecular patterns underlying distinct SLE pathologies.

Methods

Here, we integrated immune cell, protein, and transcriptome data sets with disease activity and damage indices across 87 patients with SLE to reveal three independent protein signatures corresponding to discrete organ pathologies and immune perturbations.

Results

Alongside type I interferon and granulocyte pathways, our multidimensional analyses identified a previously uncharacterized immune cell priming protein signature that was enriched in patients with renal involvement and was indicative of elevated risk of six‐year organ damage accrual. This minimally invasive signature outperformed conventional assessments and was only found in the serum proteomics data. Collectively, the protein signatures demonstrated a combined prevalence of 94%, reflecting their broad relevance to SLE.

Conclusion

Together, these results reveal parallel immune mechanisms in SLE and provide a framework to identify new therapeutic targets. Clinical and immune data are available for public exploration through the interactive SLE Immune Atlas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicHumansMultiomicsPrognosisFemaleProteomicsInterferon Type IGene Expression ProfilingTranscriptomeMaleGranulocytesAdult

Substanzen

Interferon Type I

Autor:innen und Institutionen

  • BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland.
  • Data Science and AI, AstraZeneca, Gaithersburg, Maryland.
  • Data Science and AI, AstraZeneca, Cambridge, United Kingdom.
  • Lupus Clinical Trials Unit, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, Maryland.
  • Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, Maryland.
  • Office of the Clinical Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, Maryland. Authors Smith, Wang, and Zerrouki's current address is Horizon Therapeutics, Rockville, Ma…

ORCID-Profile: Sarthak Gupta, Richard M Siegel, Kerry A Casey

Förderung

  • Intramural NIH HHS
  • AstraZeneca

Zitieren

APA

Smith, M. A., Sinibaldi, D., Rahman, S., Chiang, C. C., Hansen, A. M., Henault, J., Roca, C. P., Wang, S., Zerrouki, K., Filippi, R., Groves, C., Manna, Z., Chu, J., Davis, M., Gupta, S., Morehouse, C., de Los Reyes, M., Ettinger, R., Kolbeck, R., …, & Casey, K. A. (2026). Multi‐Omic Profiling Reveals Immune Cell Priming Signature Linked to Lupus Prognosis. Arthritis & Rheumatology. https://doi.org/10.1002/art.70105

Vancouver

Smith MA, Sinibaldi D, Rahman S, Chiang CC, Hansen AM, Henault J, et al. Multi‐Omic Profiling Reveals Immune Cell Priming Signature Linked to Lupus Prognosis. Arthritis & Rheumatology. 2026. doi:10.1002/art.70105

BibTeX
@article{Smith2026,
  author = {Smith, Michael A and Sinibaldi, Dominic and Rahman, Saifur and Chiang, Chia-Chien and Hansen, Anna M and Henault, Jill and Roca, Carlos P and Wang, Shu and Zerrouki, Kamelia and Filippi, Rebecca and Groves, Christopher and Manna, Zerai and Chu, Jun and Davis, Michael and Gupta, Sarthak and Morehouse, Christopher and de Los Reyes, Melissa and Ettinger, Rachel and Kolbeck, Roland and Kaplan, Mariana J and Sanjuan, Miguel A and Siegel, Richard M and Hasni, Sarfaraz A and Casey, Kerry A},
  title = {Multi‐Omic Profiling Reveals Immune Cell Priming Signature Linked to Lupus Prognosis},
  journal = {Arthritis & Rheumatology},
  year = {2026},
  doi = {10.1002/art.70105}
}
Kostenlos starten →